ResearchARDX
ARDX: FY25 Deep Dive
Published 1 min read
Summary
Ardelyx FY25 at $407M. NI $-62M; EPS $-0.26.
FY25 revenue $407M; OI $-41M; NI $-62M; EPS $-0.26.
Ardelyx FY25 (Dec 31, 2025) at $407M revenue. OpInc $-41M; NI $-62M; EPS $-0.26. Pharma — Specialty.
